
AnPac Bio-Medical Science Co., Ltd. ANPC
Annual report 2022
added 12-27-2025
AnPac Bio-Medical Science Co., Ltd. DPO Ratio 2011-2026 | ANPC
Annual DPO Ratio AnPac Bio-Medical Science Co., Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 238 | 155 | 94 | 54.3 | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 238 | 54.3 | 135 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aquestive Therapeutics
AQST
|
395 | $ 3.88 | -1.27 % | $ 415 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
31.7 | $ 19.23 | - | $ 899 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
72.6 | $ 0.71 | 17.15 % | $ 8.13 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
1.79 K | - | -5.98 % | $ 34.1 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.65 | 0.76 % | $ 16.6 M | ||
|
Dynavax Technologies Corporation
DVAX
|
52.8 | - | - | $ 2.02 B | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Eton Pharmaceuticals
ETON
|
74.3 | $ 22.97 | -3.53 % | $ 618 M | ||
|
Exelixis
EXEL
|
148 | $ 41.57 | 0.39 % | $ 11.3 B | ||
|
Fortress Biotech
FBIO
|
581 | $ 2.92 | -2.01 % | $ 60.7 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.31 | -2.49 % | $ 826 M |